Gabrielsen Comments on Trump Administration’s Imposition of New Limits on ‘Guidance Documents’
February 10, 2018
The New York Times
Associate Lindsey Gabrielsen is quoted in a New York Times article, “Administration Imposes Sweeping Limits on Federal Actions Against Companies,” about the ramifications of the Justice Department’s adoption of new limits on the use of ‘guidance documents” by federal agencies.
In view of the new policy, Gabrielsen said, the government “will face serious hurdles” in enforcement actions based on violations of health care guidance documents.
Gabrielsen’s comments to the New York Times were also republished in Esquire, FierceHealthcare and MSN.
In view of the new policy, Gabrielsen said, the government “will face serious hurdles” in enforcement actions based on violations of health care guidance documents.
Gabrielsen’s comments to the New York Times were also republished in Esquire, FierceHealthcare and MSN.
Related News
February 6, 2026
In the News
Louis Lehot Featured for Insights on Evolution of Dealmaking
Foley & Lardner LLP partner Louis Lehot highlighted the evolution of dealmaking in the Silicon Valley Business Journal article, "The Old Playbook Doesn't Work Anymore."
February 6, 2026
In the News
Gregory Husisian on What U.S.-India Trade Deal Means for Fashion Supply Chains
Foley & Lardner LLP Gregory Husisian discussed the broader geopolitical evolution of the US-India agreement in the Vogue Business article, “What the US-India Trade Deal Could Mean for Fashion’s Supply Chains.”
February 2, 2026
In the News
Aaron Maguregui Outlines AI Regulation and Pharma Challenges in Health Care
Foley & Lardner LLP partner Aaron Maguregui examining the regulatory landscape for AI in the health care industry in the PharmaVoice article, “As artificial intelligence increasingly takes on new patient-facing roles, laws lag behind.”